EUVIMEDEUVIMED entdecken
Crossref

The cost–benefit and ethics of Covid-19 vaccine mandates in New Zealand

Martin Lally

Monash Bioethics Review · 2026-12 · 44 (2) · 233-257

DOI: 10.1007/s40592-026-00284-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Monash Bioethics Review, online erschienen am 01.04.2026. Verfasst von Martin Lally. Beteiligte Einrichtung: Capital Financial Consultants Ltd, Wellington, New Zealand. lallym@xtra.co.nz. Hauptthemen laut MEDLINE: COVID-19 Vaccines, COVID-19, Mandatory Vaccination, Cost-Benefit Analysis. Die Arbeit nennt 36 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19 VaccinesCOVID-19Mandatory VaccinationCost-Benefit AnalysisMandatory ProgramsVaccinationHumansNew ZealandSARS-CoV-2

Stichwörter der Autor:innen

Covid-19New ZealandVaccine Mandates

Substanzen

COVID-19 Vaccines

Autor:innen und Institutionen

  • Capital Financial Consultants Ltd, Wellington, New Zealand. lallym@xtra.co.nz.

Zitieren

APA

Lally, M. (2026). The cost–benefit and ethics of Covid-19 vaccine mandates in New Zealand. Monash Bioethics Review, 44(2), 233-257. https://doi.org/10.1007/s40592-026-00284-3

Vancouver

Lally M. The cost–benefit and ethics of Covid-19 vaccine mandates in New Zealand. Monash Bioethics Review. 2026;44(2):233-257. doi:10.1007/s40592-026-00284-3

BibTeX
@article{Lally2026,
  author = {Lally, Martin},
  title = {The cost–benefit and ethics of Covid-19 vaccine mandates in New Zealand},
  journal = {Monash Bioethics Review},
  year = {2026},
  volume = {44},
  number = {2},
  pages = {233--257},
  doi = {10.1007/s40592-026-00284-3}
}
Kostenlos starten →